Fresh news on culture and lifestyle in the Netherlands
Provided by AGP
By AI, Created 10:15 AM UTC, May 25, 2026, /AGP/ – Maximize Market Research says the global cannabidiol market will rise from $10.04 billion in 2025 to $26.72 billion by 2032. Growth is being driven by broader legalization, stronger consumer demand for plant-based wellness products, and expanding use across healthcare, cosmetics and food and beverages.
Why it matters: - The cannabidiol market is moving from a niche wellness category into a broader consumer and healthcare segment. - The forecast implies sustained demand for CBD products across pain management, anxiety relief, sleep support, skincare and functional foods. - The market’s expansion could create new opportunities for manufacturers, retailers, investors and pharmaceutical developers.
What happened: - Maximize Market Research projected the global Cannabidiol (CBD) Market will grow from USD 10.04 billion in 2025 to USD 26.72 billion by 2032. - The forecast calls for a 15.01% compound annual growth rate over the period. - The report was released from Austin, Texas, on May 25, 2026. - The analysis covers demand across healthcare, cosmetics, food and beverages, and personal wellness. - More information
The details: - Cannabidiol is a non-psychoactive compound derived from cannabis plants. - The report says consumers are using CBD products for pain management, anxiety reduction, stress relief, sleep disorders, inflammation control and general wellness. - The market includes hemp-derived CBD and marijuana-derived CBD. - Hemp-derived CBD leads the market because of lower THC content and a more favorable legal status in several countries. - CBD oils and tinctures hold a significant share because they are easy to use and dose. - CBD-infused edibles and beverages are gaining traction, especially with younger consumers. - Pain management remains one of the leading applications because consumers are looking for alternatives to opioid-based medicines. - Online retail is growing quickly because e-commerce is expanding and buyers want discreet purchasing options. - North America leads the global market because of legalization, high consumer awareness, strong retail infrastructure and investment in cannabis research. - The United States is the largest contributor, and Canada remains important because of its legalized cannabis industry and regulatory framework. - Europe is seeing rapid expansion, with Germany, the United Kingdom, Switzerland and the Netherlands among the markets adopting CBD products. - Asia-Pacific is described as a future growth region, with Thailand, Australia, South Korea and Japan gradually expanding cannabis-related healthcare initiatives. - The report flags emerging opportunities in pharmaceuticals, nutraceuticals, veterinary products, food, sports recovery and functional beverages.
Between the lines: - The report frames CBD as part of a larger shift toward natural wellness and preventive healthcare. - Legal changes are central to the market story because they affect product access, retail expansion and investor confidence. - The report also suggests consumer interest in stress management and sleep support may benefit CBD demand during periods of geopolitical uncertainty. - That said, the forecast is still dependent on continued regulatory progress and steady commercialization across regions.
What’s next: - Product innovation is expected to continue, including flavored gummies, wellness beverages, beauty creams and prescription-grade formulations. - Pharmaceutical companies, nutraceutical makers, cosmetic brands and wellness startups are likely to keep investing in CBD research and development. - The Asia-Pacific region may attract more attention as regulations evolve and healthcare adoption widens. - The report expects long-term growth to continue as governments refine cannabis rules and scientific research expands.
The bottom line: - CBD is shifting from an emerging wellness ingredient into a mainstream global market, with legalization, product innovation and wider therapeutic use driving the next phase of growth.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
The daily local news briefing you can trust. Every day. Subscribe now.
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
is already signed up. Check your inbox for updates.